UCB - M&A Summary and Business Overview

Healthcare ServicesCompany

UCB M&A Summary

UCB has acquired 11 companies, including 4 in the last 5 years. It has also divested 7 assets.

UCB’s largest acquisition to date was in 2006, when it acquired Schwarz Pharma AG for $5.6B. It’s largest disclosed sale occurred in 2015, when it sold Kremers Urban Pharmaceuticals to Lannett Company for $1.2B. UCB has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (64%) and medical products (28%).

UCB Business Overview

Where is UCB headquartered?

UCB is headquartered in Brussels, Belgium.

What is UCB’s revenue?

UCB disclosed revenue of 5,252M EUR for 2023 and 5,517M EUR for 2022.

How many employees does UCB have?

UCB has 9,000 employees.

What sector is UCB in?

UCB is a healthcare services company.

When was UCB founded?

UCB was founded in 1928.

M&A Summary

  • M&A Total Activity18
    • M&A Buy Activity11
    • M&A Sell Activity7
  • Total Sectors Invested 3
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 8
  • M&A Advisors 6

UCB

UCB S.A.

Allee de la Recherche, 60,
Brussels, 1070
Belgium,
+32 2 559 99 99
www.ucb.com

UCB is a biopharma focused on severe diseases with operations in approximately 40 countries. UCB was incorporated in 1928 and is based in Brussels, Belgium.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # 8 1 - 1 - 1 11
vol $10.9B $270M $1.9B $13.1B
Sell (0.0/yr) # 7 - - - - - 7
vol $2.1B $2.1B
  18

Most Recent M&A

Company Date Value Type
IMIDomics, Inc. 2024-03-04 - Add-on Acquisition
San Rafael, California · www.imidomics.com.
Zogenix, Inc. 2022-01-19 1.9B USD Add-on Acquisition
Emeryville, California · www.zogenix.com
Engage Therapeutics, Inc. 2020-06-05 270M USD Add-on Acquisition
Summit, New Jersey · www.engagetherapeutics.com
Ra Pharmaceuticals, Inc. 2019-10-10 2.5B USD Add-on Acquisition
Cambridge, Massachusetts · www.rapharma.com
APONTIS PHARMA GmbH & Co. KG 2018-07-30 - Divestiture
Monheim am Rhein, Germany · www.apontis-pharma.de
Beryllium Discovery LLC 2017-06-06 - Add-on Acquisition
Bedford, Massachusetts · www.be4.com
International Medication Systems (UK) Ltd. 2016-08-04 8M USD Divestiture
Berkshire, United Kingdom
UCB - Three Cardiovascular Products 2016-02-01 104M EUR Divestiture
, Belgium
Kremers Urban Pharmaceuticals, Inc. 2015-11-27 1.2B USD Divestiture
Princeton, New Jersey · www.kremersurban.com
Lectus Therapeutics - Pharmaceutical Assets 2011-11-22 - Divestiture
, United Kingdom
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 7 (64%) 5.2B (40%) 6 (86%) 2.0B (95%)
Medical Products 3 (27%) 5.6B (43%) 1 (14%) 104M (5%)
Healthcare Services 1 (9%) 2.3B (18%) - -
Total 11 $13.1B 7 $2.1B

By Geo

State/Country Buy Value Sell Value
United States 8 5.2B 1 1.2B
  Massachusetts 2 2.5B - -
  Georgia 2 - - -
  California 2 1.9B - -
  New Jersey 1 270M 1 1.2B
  Missouri 1 500M - -
Belgium - - 3 819M
United Kingdom 2 2.3B 1 8M
Germany 1 5.6B 1 -
France - - 1 -
Domestic - - 3 (43%) 819M (40%)
Cross-border 11 (100%) 13.1B (100%) 4 (57%) 1.2B (60%)
Total 11 $13.1B 7 $2.1B

Top M&A Advisors

Financial Deals
Lazard
3
Barclays Investment Bank
1
Daiwa Corporate Advisory Ltd. (DC Advisory)
1
Legal Deals
Covington & Burling
3
Hengeler Mueller
1

Deal Values

buy # Total
> $1B 4 $12.3B
$100M to $1B 2 $770M
TOTAL $13.1B
Largest Schwarz Pharma AG
$5.6B (2006-09-26)
sell # Total
> $1B 1 $1.2B
$100M to $1B 3 $819M
< $100M 1 $8M
TOTAL $2.1B
Largest Kremers Urban Pharmaceuticals, Inc.
$1.2B (2015-11-27)

M&A Connections

Deals
Acquired from
Strategic(s)
18%
2 (18%)
Divested to
Investor(s)
14%
1 (14%)
Strategic(s)
71%
5 (71%)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.